CERA vs other ESA
Adverse events: hypertension · patients with the anaemia of end‐stage kidney disease undergoing dialysis
CERA showed no clear difference in numbers of adverse events due to hypertension: CERA every 2 weeks… compared with other ESA (high certainty).
1 finding from 1 review
- Frequency of administration of erythropoiesis‐stimulating agents for the anaemia of end‐stage kidney disease in… 2014 · Cochrane Headline outcomes onlyRR 0.93 [0.69, 1.26]4 studies · 1341 participantsHigh